Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 14;10(8):1311.
doi: 10.3390/vaccines10081311.

Vaccinations Status against Vaccine-Preventable Diseases and Willingness to Be Vaccinated in an Italian Sample of Frail Subjects

Caterina De Sarro  1 , Rosa Papadopoli  1 , Maria Carmela Morgante  1 , Carmelo Giuseppe Angelo Nobile  2 , Giovambattista De Sarro  1   3 , Claudia Pileggi  1   3
Affiliations

Vaccinations Status against Vaccine-Preventable Diseases and Willingness to Be Vaccinated in an Italian Sample of Frail Subjects

Caterina De Sarro et al. Vaccines (Basel). .

Abstract

Background: Study aim was to investigate the vaccination status against vaccine-preventable diseases (VPD) of frail adults during the SARS-CoV-2 pandemic and, for those subjects eligible for at least one vaccine, with respect to the recommended vaccination in line with the Italian National Vaccination Prevention Plane (NPVP), to explore the willingness to be vaccinated.

Methods: A cross-sectional study was carried out among adults aged ≥ 60, immunocompromised or subjects affected by chronic conditions.

Results: Among the 427 participants, a vaccination coverage rate lower than the targets for all the vaccines considered was found. Of those, 72.6% of subjects stated their willingness to receive recommended vaccinations, and 75.2% of the respondents stated that the advice to undergo vaccinations was received by the General Practitioner (GP). In a multivariable logistic regression model, higher odds of recommended VPD vaccination uptake (defined as having two or more of the recommended vaccinations) were associated with the willingness towards recommended VPD vaccination (Odds Ratio = 3.55, 95% Confidence Interval: 1.39 to 9.07), university education (OR = 2.03, 95% CI: 1.03 to 3.97), but having another person in the household (OR = 0.52, 95% CI: 0.28 to 0.97), and history of oncological disease (OR = 0.39, 95% CI: 0.18 to 0.87) were predictive of lower odds of vaccination uptake. In another multivariable model, higher odds of willingness to receive vaccines were associated with kidney disease (OR = 3.3, 95% CI: 1.01 to 10.5), perceived risk of VPD (OR = 1.9, 95% CI: 1.02 to 3.3), previous influenza vaccination (OR = 3.4, 95% CI: 1.8 to 6.5), and previous pneumococcal vaccination (OR = 3.1, 95% CI: 1.3 to 7.7), but increasing age (OR = 0.93 per year, 95% CI: 0.91 to 0.97), working (OR = 0.40, 95% CI: 0.20 to 0.78), and fear of vaccine side effects (OR = 0.38, 95% CI: 0.21 to 0.68) were predictive of lower odds of willingness to receive vaccines.

Conclusions: Despite specific recommendations, vaccination coverage rates are far below international targets for frail subjects. Reducing missed opportunities for vaccination could be a useful strategy to increase vaccination coverage in frail patients during the routine checks performed by GPs and specialists.

Keywords: frail patients; missed opportunities; recommended vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Italian Ministry of Health National Prevention Vaccine Plan 2017–2019. [(accessed on 21 February 2022)]; Official Gazette no. 41 of 18 February 2017. Available online: https://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf.
    1. World Health Organization (WHO) Global Vaccine Action Plan 2011–2020. World Health Organization; Geneva, Switzerland: 2013. [(accessed on 25 March 2022)]. Available online: https://www.who.int/teams/immunization-vaccines-and-biologicals/strategi....
    1. Immunization Agenda 2030 (IA2030). A Global Strategy to Leave No One Behind. [(accessed on 25 March 2022)]. Available online: http://www.immunizationagenda2030.org/
    1. Lupica A., Di Stefano V., Iacono S., Pignolo A., Quartana M., Gagliardo A., Fierro B., Brighina F. Impact of COVID-19 in AChR Myasthenia Gravis and the safety of vaccines: Data from an Italian cohort. Neurol. Int. 2022;14:406–416. doi: 10.3390/neurolint14020033. - DOI - PMC - PubMed
    1. Caglioti A., Rania V., Vocca C., Marcianò G., Arcidiacono V., Catarisano L., Casarella A., Basile E., Colosimo E., Palleria C., et al. Effectiveness and Safety of ANTI SARS-CoV-2 Vaccination in Transplant Patients Treated with Immunosuppressants: A Real-World Pilot Study with a 1-Year Follow-Up. Appl. Sci. 2022;12:6103. doi: 10.3390/app12126103. - DOI

LinkOut - more resources